 ROCKVILLE, Md., Sept. 07, 2022 GLOBE NEWSWIRE -- MaxCyte, Inc., NASDAQ: MXCT; LSE: MXCT, a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization, today announced Company management will present at the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13th at 4:40 p.m. Eastern Time. 